Showing results (1011-1020 of 1,194) with videos related to

Sort By:
Pageof 120
Cancer Cell|March 12, 2015
A functional landscape of resistance to ALK inhibition in lung cancerFrederick H Wilson, Cory M Johannessen, Federica Piccioni, et al.
Journal of Medicinal Chemistry|October 25, 2024
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB InhibitorAntonius Ter Laak, Roman C Hillig, Steven J Ferrara, et al.
Hematology (Amsterdam, Netherlands)|January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Genes, Chromosomes & Cancer|December 8, 2007
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patientsKenneth D Swanson, Jordan M Winter, Marcelo Reis, et al.
British Journal of Haematology|July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab eraAdam G Starr, Paolo F Caimi, PingFu Fu, et al.
Oncogene|June 10, 2014
Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequencesT J Pugh, W Yu, J Yang, et al.
Plos One|September 26, 2013
Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequencyMegan C Hanna, Christina Go, Christine Roden, et al.
Cancer Research|July 18, 2008
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistanceTakeshi Shimamura, Danan Li, Hongbin Ji, et al.
Cancer Research|December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaMohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2009
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomasDariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, et al.
Pageof 120